Transforming growth factor-β 1 regulation of C-type natriuretic peptide expression in human vascular smooth muscle cells: Dependence on TSC22D1

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 6, 2010, Pages

  Mendonça, Maria C ^a   Koles, Nancy ^a   Doi, Sonia Q ^a   Sellitti, Donald F ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Fibroblast; Platelet derived growth factor; Serine threonine kinase 16; Transcription factor; Transforming growth factor stimulated clone domain family

Indexed keywords

LEUCINE ZIPPER PROTEIN; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; PLATELET DERIVED GROWTH FACTOR BB; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

AORTA; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA TRANSCRIPTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NATRIURETIC PEPTIDE, C-TYPE; PLATELET-DERIVED GROWTH FACTOR; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 78649742897     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00656.2010     Document Type: Article

References (27)

1. Chun TH, Itoh H, Saito T, Yamahara K, Doi K, Mori Y, Ogawa Y, Yamashita J, Tanaka T, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Nakao K. Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin. J Hypertens 18: 575-580, 2000.
2. Fiol DF, Mak SK, Kültz D. Specific TSC22 domain transcripts are hypertonically induced and alternatively spliced to protect mouse kidney cells during osmotic stress. FEBS J 274: 109-124, 2007.
3. Fukunaga Itoh H, Doi K, Tanaka T, Yamashita J, Chun TH, Inoue M, Masatsugu K, Sawada N, Saito T, Hosoda K, Kook H, Ueda M, Nakao K. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides. Atherosclerosis 158: 113-119, 2001.
4. Furaya M, Aisaka K, Miyazaki T, Honbou N, Kawashima N, Ohno T, Tanaka S, Minamino N, Kangawa K, Matsuo H. C-type natriruetic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun 193: 248-253, 1993.
5. Gardner D, Chen S, Glenn DJ, Grigsby CL. Molecular biology of the natriuretic peptide system. Implications for physiology and hypertension. Hypertension 49: 419-426, 2007.
6. Gluderer S, Brunner E, Germann M, Jovaisaite V, Li C, Rentsch CY, Hafen E, Stocker H. Madm (Mlf1 adapter molecule) cooperates with bunched A to promote growth in drosophila. J Biol 9: 9-24, 2010.
7. Guinea B, Ligos J, de Lera TL, Martin-Caballero J, Flores J, de la Pena M, Garcia-Castro J, Bernad A. Nucleocytoplasmic shuttling of STK16 (PKL12), a Golgi-resident serine/threonine kinase involved in VEGF expression regulation. Exp Cell Res 312: 135-144, 2006.
8. Iida M, Anna CH, Gaskin ND, Walker NJ, Devereux TR. The putative tumor suppressor Tsc-22 is downregulated early in chemically induced hepatocarcinogenesis, and may be a suppressor of Gadd45b. Toxicol Sci 99: 43-50, 2007.
9. 1 in intimal thickening after vascular injury. Cardiovasc Res 74: 223-234, 2007.
10. 1 and its receptors by the kruppel-like factor Zf9/core promoter-binding protein and Sp-1. J Biol Chem 273: 33750-33758, 1998.
11. Mendonça MC, Doi SQ, Glerum S, Sellitti DF. Increase of C-type natriuretic peptide expression by serum and platelet-dervived growth factor-BB in human aortic smooth muscle cells is dependent on protein kinase C activation. Endocrinology 147: 4169-4178, 2006.
12. Mendonca MC, Rezende A, Doi SQ, Sellitti DF. Lysophosphatidylcholine increases C-type natriuretic peptide expression in human vascular smooth muscle cells via membrane distortion. Vascul Pharmacol 51: 29-36, 2009.
13. Naruko T, Itoh A, Haze K, Ehara S, Fukushima H, Sugama Y, Shirai N, Ikura Y, Ohsawa M, Ueda M. C-type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. Atherosclerosis 181: 241-250, 2005.
14. Naruko T, Ueda M, van der Wal AC, van der Loos CM, Itoh H, Nakao K, Becker AE. C-type natriuretic peptide in human atherosclerotic lesions. Circulation 94: 3103-3108, 1996.
15. Ohno N, Itoh H, Ikeda T, Ueyama K, Yamahara K, Doi K, Yamashita J, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Sakaguchi S, Sone M, Yurugi T, Kook H, Komeda M, Nakao K. Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriruetic peptide. Circulation 105: 1623-1626, 2002.
16. Ohta S, Shimekake Y, Nagata K. Cell-type-specific function of the C-type natriuretic peptide gene promoter in rat anterior pituitary-derived cultured cell lines. Mol Cellul Biol 13: 4077-4086, 1993.
17. Ohta S, Shimekake Y, Nagata K. Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur J Biochem 242: 460-466, 1996.
18. Ohta S, Takeuchi M, Deguchi., Tsuji Y, Gahara K, Nagata A. A novel transcriptional factor with ser/thr kinase activity in the transforming growth factor (TGF)-β signaling pathway. Biochem J 350: 395-404, 2000.
19. Parmar KM, Larman B, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA, García-Cardeña G. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 116: 49-58, 2006.
20. Potter LR, Abbey-Hoesch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic-guanosine monophosphate- dependent signaling functions. Endocr Rev 27: 47-72, 2006.
21. Qian JY, Haruno A, Asada Y, Nishida T, Saito Y, Matsuda T, Ueno H. Local expression of C-type natriruetic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ Res 91: 1063-1069, 2002.
22. Sellitti DF, Puggina E, Lagranha C, Doi SQ, Pithon-Curi T, Kohn LD, Suzuki K. TGF-beta-like transcriptional effects of thyroglobulin (Tg) in mouse mesangial cells. Endocr J 54: 449-458, 2007.
23. 1 and other growth factors. J Biol Chem 267: 10219-10224, 1992.
24. Soeki T, Kishimoto I, Okumura H, Tokudome T, Mori K, Kangawa K. C-type natriruetic peptide, a novel antifibrotic and anti hypertrophic agent, prevents cardiac remodeling after myocardial infarction. J A Coll Cardiol 45: 608-616, 2005.
25. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide, and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system." J Clin Invest 90: 1145-1149, 1992.
26. Surendran K, Simon TC. CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury. Am J Physiol Renal Physiol 284: F653-F662, 2003.
27. Thompson IR, Chand AN, Jonas KC, Burrin JM, Steinhelper ME, Wheeler-Jones CP, McArdle CA, Fowkes RC. Molecular characterization and function interrogation of a local natriuretic peptide system in rodent pituitaries, αT3-1 and LβT2 gonadotroph cells. J Endocrinol 203: 215-229, 2009.